AMRN (Amarin Corp Plc)
Insider Trading Activity
Every open-market purchase and sale reported by AMRN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2026-07-15 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2026-07-15 | Steven B Ketchum | EVP, Chief Scientific Officer | MIXED | — | — |
| 2026-07-15 | David Paul Keenan | EVP, Chief Operating Officer | MIXED | — | — |
| 2026-07-15 | Jonathan Provoost | EVP, Chief Legal Officer | MIXED | — | — |
| 2026-04-22 | Patrice Eadon Bonfiglio | Director | MIXED | — | — |
| 2026-04-21 | Kostas D Odysseas | Director | MIXED | — | — |
| 2026-04-21 | Keith Horn | Director | MIXED | — | — |
| 2026-04-21 | Paul Cohen | Director | MIXED | — | — |
| 2026-04-21 | Diane E. Sullivan | Director | MIXED | — | — |
| 2026-04-21 | Oliver O'Connor | Director | MIXED | — | — |
| 2026-04-21 | Louis Sterling III | Director | MIXED | — | — |
| 2026-04-02 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2026-02-03 | Jonathan Provoost | EVP, Chief Legal Officer | A | — | — |
| 2026-02-03 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2026-02-03 | Aaron Berg | President and CEO | MIXED | — | — |
| 2026-02-03 | David Paul Keenan | EVP, Chief Operating Officer | MIXED | — | — |
| 2026-02-03 | Steven B Ketchum | EVP, Chief Scientific Officer | MIXED | — | — |
| 2026-01-06 | Steven B Ketchum | EVP, Chief Scientific Officer | MIXED | — | — |
| 2026-01-06 | David Paul Keenan | EVP, Chief Operating Officer | MIXED | — | — |
| 2026-01-06 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2026-01-06 | Jonathan Provoost | EVP, Chief Legal Officer | MIXED | — | — |
| 2025-08-04 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2025-06-30 | Aaron Berg | President and CEO | MIXED | — | — |
| 2025-04-22 | Patrice Eadon Bonfiglio | Director | MIXED | — | — |
| 2025-04-22 | Kostas D Odysseas | Director | MIXED | — | — |
| 2025-04-22 | Louis Sterling III | Director | MIXED | — | — |
| 2025-04-22 | Diane E. Sullivan | Director | MIXED | — | — |
| 2025-04-22 | Oliver O'Connor | Director | MIXED | — | — |
| 2025-04-22 | Mark DiPaolo | Director | MIXED | — | — |
| 2025-04-22 | Keith Horn | Director | MIXED | — | — |
| 2025-04-22 | Paul Cohen | Director | MIXED | — | — |
| 2025-04-09 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2025-01-31 | Aaron Berg | President and CEO | MIXED | — | — |
| 2025-01-31 | Steven B Ketchum | Chief Scientific Officer | MIXED | — | — |
| 2025-01-31 | Peter L. Fishman | SVP, CFO | MIXED | — | — |
| 2025-01-10 | Peter L. Fishman | SVP, CFO | A | — | — |
| 2025-01-10 | Jonathan Provoost | EVP, Chief Legal Officer | A | — | — |
| 2025-01-10 | Steven B Ketchum | Chief Scientific Officer | A | — | — |
| 2024-08-05 | Aaron Berg | President and CEO | Buy | — | — |
| 2024-08-01 | Aaron Berg | President and CEO | MIXED | — | — |
| 2024-08-01 | Steven B Ketchum | Chief Scientific Officer | MIXED | — | — |
| 2024-07-01 | Thomas Charles Reilly | EVP and CFO | MIXED | — | — |
| 2024-06-21 | Thomas Charles Reilly | EVP and CFO | MIXED | — | — |
| 2024-04-19 | Kostas D Odysseas | Director | A | — | — |
| 2024-04-19 | Louis Sterling III | Director | A | — | — |
| 2024-04-19 | Mark DiPaolo | Director | A | — | — |
| 2024-04-19 | Oliver O'Connor | Director | A | — | — |
| 2024-04-19 | Diane E. Sullivan | Director | A | — | — |
| 2024-04-19 | Paul Cohen | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 605,984 | — |
| — | 10%+ Owner | 446,914 | — |
| — | 10%+ Owner | 425,669 | — |
| — | Director | 345,455 | — |
| — | Director | 320,579 | — |
| — | President and CEO | 162,157 | — |
| — | 10%+ Owner | 114,058 | — |
| — | President and CEO | 82,960 | — |
| — | Director | 59,430 | — |
| — | EVP, Chief Scientific Officer | 42,680 | — |
| — | President and CEO | 16,124 | — |
| — | General Counsel | 15,893 | — |
| — | President and CEO | 15,721 | — |
| — | EVP, Chief Operating Officer | 15,396 | — |
| — | SVP and CFO | 14,233 | — |
| — | Director | 10,878 | — |
| — | Director | 9,827 | — |
| — | Director | 8,551 | — |
| — | SVP, CFO | 7,619 | — |
| — | Director | 6,000 | — |
| — | EVP and CFO | 4,715 | — |
| — | EVP, Chief Legal Officer | 4,624 | — |
| — | Director | 4,452 | — |
| — | SVP and Head of Development | 4,000 | — |
| — | Director | 2,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AMRN quote page; the site-wide leaderboard is on the insider transactions hub.